Stigma, Risk Behaviors and Health Care among HIV-infected Russian People Who Inject Drugs

俄罗斯艾滋病毒感染者注射吸毒者的耻辱、危险行为和医疗保健

基本信息

  • 批准号:
    9767759
  • 负责人:
  • 金额:
    $ 24.78万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-09-01 至 2021-08-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): People who inject drugs (PWID) and live with HIV infection often experience double stigmatization. Stigma, the exclusion and dehumanization of individuals in an undesirable social category, may have adverse effects on risk behaviors and health care utilization among PWID. With the SCRIPT (Stigma Coping to Reduce HIV risks and Improve substance use Prevention and Treatment) study, I seek to extend my expertise in addiction medicine and public health to adapt and evaluate interventions addressing the double stigma for PWID living with HIV through these training goals: 1) to apply behavioral theories to understand and address stigma among PWID living with HIV; 2) to analyze stigma and its relation to HIV risks and health care utilization; 3) to acquire competence in the adaptation of a stigma-reduction intervention; 4) to gain expertise in planning and implementing a pilot study of this intervention. Stigmatizing attitudes by others lead to self-stigma, which can have an adverse impact on risk behaviors, addiction treatment and HIV care seeking. Yet, self-stigma has received limited attention in studies conducted among HIV-infected PWID. The SCRIPT study proposes to make use of existing data from NIH-supported studies with HIV-infected PWID in Russia to examine factors affecting the double stigma and its role in substance use and health care utilization in this key population. I also propose to begin to address the problem by adapting and pilot-testing a stigma intervention. In the mentored K99 phase, I will conduct secondary analysis of existing quantitative data from HIV-infected PWID in Russia (n=360) and examine substance use and social factors that affect HIV self-stigma, substance use self-stigma, and stigma's role on health care utilization and risks for HIV transmission. To enhance our understanding of how to address these issues, I will conduct a qualitative study to further explore potentially modifiable aspects of stigma. This will inform the adaptation of an intervention for PWID living with HIV to address stigma. The training and the mentored research related to the SCRIPT study will be essential to my transition to independent stigma researcher. For the R00 phase, I propose to adapt and pilot- test a stigma intervention to target PWID to empower them to cope with shame and avoidance related to stigma. This pilot study will lay the base for an R01 application for a larger randomized control trial of a stigma intervention for PWID.
 描述(由应用程序提供):注射药物(PWID)并患有艾滋病毒感染的人通常会遭受双重污名化。在不良社会类别中,个人的污名化,个人的排斥和非人性化可能会对PWID之间的风险行为和医疗保健利用产生不利影响。借助脚本(降低艾滋病毒风险并改善药物使用预防和治疗)的脚本研究,我试图扩展我在成瘾医学和公共卫生方面的专业知识,以适应和评估通过这些培训目标来适应艾滋病毒的双重污名的干预措施:1),以应用行为理论,以了解和解决PWID的HIV居住在PWID HIV中的污名化; 2)分析污名及其与艾滋病毒风险和医疗保健利用的关系; 3)获得适应污名干预措施的能力; 4)在计划和实施此干预的试点研究方面获得专业知识。其他人的污名参与者会导致自我污名,这可能会对风险行为,成瘾治疗和寻求艾滋病毒护理产生不利影响。然而,在感染HIV感染的PWID的研究中,自我污名受到了有限的关注。脚本研究的提案旨在利用NIH支持研究的现有数据在俄罗斯艾滋病毒感染的PWID,以研究影响双重污名的因素及其在这一关键人群中的作用和在药物使用和医疗保健利用中的作用。我还建议通过调整和试点测试污名干预来开始解决问题。在修订的K99阶段中,我将对俄罗斯HIV感染的PWID的现有定量数据进行次要分析(n = 360),并检查影响HIV自我污名的物质使用和社会因素,以及污名化的自我污名,以及污名在医疗保健利用率上的作用和HIV传播风险。为了增强我们对如何解决这些问题的理解,我将进行一项定性研究,以进一步探索污名的潜在修改方面。这将告知适应艾滋病毒的PWID生活的干预措施,以应对污名。与脚本研究相关的培训和指导研究对于我向独立污名研究者的过渡至关重要。对于R00阶段,我提议适应和进行试验 - 测试污名干预措施,以靶向PWID,以使其能够应对与污名相关的羞耻和回避。这项初步研究将为R01应用奠定基础,以进行较大的PWID污名干预措施的随机对照试验。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Karsten Lunze其他文献

Karsten Lunze的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Karsten Lunze', 18)}}的其他基金

Community-engaged implementation strategies for acceptance interventions to improve access to care for people with HIV and injection drug use
社区参与的接受干预实施战略,以改善艾滋病毒感染者和注射吸毒者获得护理的机会
  • 批准号:
    10762655
  • 财政年份:
    2023
  • 资助金额:
    $ 24.78万
  • 项目类别:
Gabapentin to Reduce Alcohol and Improve Viral Load Suppression - Promoting "Treatment as Prevention"
加巴喷丁减少饮酒并改善病毒载量抑制——促进“治疗即预防”
  • 批准号:
    10706554
  • 财政年份:
    2022
  • 资助金额:
    $ 24.78万
  • 项目类别:
Gabapentin to Reduce Alcohol and Improve Viral Load Suppression - Promoting "Treatment as Prevention"
加巴喷丁减少饮酒并改善病毒载量抑制——促进“治疗即预防”
  • 批准号:
    10541347
  • 财政年份:
    2022
  • 资助金额:
    $ 24.78万
  • 项目类别:
Stigma, Risk Behaviors and Health Care among HIV-infected Russian People Who Inject Drugs
俄罗斯艾滋病毒感染者注射吸毒者的耻辱、危险行为和医疗保健
  • 批准号:
    10199478
  • 财政年份:
    2018
  • 资助金额:
    $ 24.78万
  • 项目类别:
Stigma, Risk Behaviors and Health Care among HIV-infected Russian People Who Inject Drugs
俄罗斯艾滋病毒感染者注射吸毒者的耻辱、危险行为和医疗保健
  • 批准号:
    9982917
  • 财政年份:
    2018
  • 资助金额:
    $ 24.78万
  • 项目类别:
Core K - Substance Use Research Core
核心 K - 药物使用研究核心
  • 批准号:
    10197767
  • 财政年份:
    1998
  • 资助金额:
    $ 24.78万
  • 项目类别:
Core K - Substance Use Research Core
核心 K - 药物使用研究核心
  • 批准号:
    10454399
  • 财政年份:
    1998
  • 资助金额:
    $ 24.78万
  • 项目类别:

相似海外基金

Scientific Leadership Group Core
科学领导小组核心
  • 批准号:
    10595900
  • 财政年份:
    2023
  • 资助金额:
    $ 24.78万
  • 项目类别:
RP4 LEAP
RP4飞跃
  • 批准号:
    10595904
  • 财政年份:
    2023
  • 资助金额:
    $ 24.78万
  • 项目类别:
RP5 MPT Study
RP5 MPT 研究
  • 批准号:
    10595905
  • 财政年份:
    2023
  • 资助金额:
    $ 24.78万
  • 项目类别:
The roles of FRCs in HIV-1 spread and establishment of latency
FRC 在 HIV-1 传播和潜伏期建立中的作用
  • 批准号:
    10759591
  • 财政年份:
    2023
  • 资助金额:
    $ 24.78万
  • 项目类别:
Developing a Risk Index for Functional Decline in Middle-Aged and Older Adults with HIV
制定中老年艾滋病毒感染者功能衰退的风险指数
  • 批准号:
    10762280
  • 财政年份:
    2023
  • 资助金额:
    $ 24.78万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了